Most Recent
J&J talc class action a game of ‘whack-a-mole’, court told
A class action against Johnson & Johnson over allegedly carcinogenic talcum powder still can't say whether it has sued the correct entities and wants the company to sift through 100 years of corporate history to save it from playing "whack-a-mole".
Court rejects J&J’s claim ‘novel’ notice will put off class action members
A court has rejected an objection by J&J to a registration notice in a class action over cold medication that flags the applicant’s opposition to soft class closure.
IAG finalises settlement in $2.8B Credit Suisse case over Greensill
Insurance Australia Group said Friday it had settled the $2.8 billion claims of Credit Suisse over the collapse of supply chain financier Greensill Capital.
Trial set in White Oak’s Greensill case, as IAG firms up Credit Suisse pact
A judge has set down the start of trial in Greensill investor White Oak's case against Insurance Australia Group, as the insurer finalises its settlement with Credit Suisse and UBS over the collapse of the supply chain funder.
Breast implants class action takes aim again at Allergan’s ‘state of the art’ defence
A class action against Allergan over recalled breast implants is trying again to strike out the US drug company’s defence that there was no known causal link between its implants and a type of cancer at the time of supply.
Tesla’s ‘highly confidential’ systems at issue in self-driving cars class action
A judge has suggested an expert should access Tesla’s "highly, highly confidential" internal live systems amid complaints by a class action that the car maker's discovery of technical documents is inadequate.
Breast implants class action loses bid to strike out Allergan defence
A class action against Allergan over recalled breast implants has lost its bid to strike out the US drug company’s defence that there was no known causal link between its implants and a certain form of cancer at the time of supply.
Fiducian hit with $7.3M penalty over misleading ESG claims
Fiducian Investment Management has copped a $7.3 million penalty after admitting that it made misleading representations about the ESG credentials of an investment fund, despite senior execs being warned about its exposure to fossil fuels.
Class closure worth the $1M cost, judge in J&J cold meds case says
In ordering early registration for a class action against a Johnson & Johnson unit, which estimates its defence costs at over $22 million, a judge has said the "very expensive" process is appropriate.
Court orders soft class closure in J&J cold medicine class action
A judge has granted Johnson & Johnson's bid for soft class closure in a class action over alleged ineffective cold medications, saying it would aid in settlement negotiations.